The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis

The role of immunomodulatory agents in the treatment of hospitalized patients with COVID-19 has been of increasing interest. Anakinra, an interleukin-1 inhibitor, has been shown to offer significant clinical benefits in patients with COVID-19 and hyperinflammation. An updated systematic review and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyriakoulis, Konstantinos G., Kollias, Anastasios, Poulakou, Garyphallia, Kyriakoulis, Ioannis G., Trontzas, Ioannis P., Charpidou, Andriani, Syrigos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509118/
https://www.ncbi.nlm.nih.gov/pubmed/34640480
http://dx.doi.org/10.3390/jcm10194462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509118/
https://www.ncbi.nlm.nih.gov/pubmed/34640480
http://dx.doi.org/10.3390/jcm10194462

Ejemplares similares